medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (4)


The function of MicroRNA in hepatitis B virus-related liver diseases: from Dim to Bright

Yu K, Shi G, Li N

Idioma: Ingles.
Referencias bibliográficas: 64
Paginas: 450-456
Archivo PDF: 104.46 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 1976; 295: 517-22.

  2. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359: 1486-500.

  3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33.

  4. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.

  5. Arataki K, Hayes CN, Akamatsu S, Akiyama R, Abe H, Tsuge M, Miki D, et al. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med Virol 2013; 85: 789-98.

  6. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, Fei M, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56: 1830-8.

  7. Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011; 18: e242-51.

  8. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, et al. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J 2011; 25: 4511-21.

  9. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 2012; 55: 730-41.

  10. Hao J, Jin W, Li X, Wang S, Zhang X, Fan H, Li C, et al. Inhibition of alpha interferon (IFN-alpha)-induced microRNA- 122 negatively affects the anti-hepatitis B virus efficiency of IFN-alpha. J Virol 2013; 87: 137-47.

  11. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, Kronenberger B, et al. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 2012; 19: e58-65.

  12. Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, et al. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One 2012; 7: e48366.

  13. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098-112.

  14. Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One 2013; 8: e58236.

  15. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, Sun Y, et al. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 2011; 54: 808-19.

  16. Zhang H, Li QY, Guo ZZ, Guan Y, Du J, Lu YY, Hu YY, et al. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J Gastroenterol 2012; 18: 5188-96.

  17. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010; 70: 9798-807.

  18. Chen L, Li C, Peng Z, Zhao J, Gong G, Tan D. miR-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients. Gut Liver 2013; 7: 335-42.

  19. Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, et al. Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology 2011; 53: 1476-85.

  20. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 2011; 39: 5157-63.

  21. Hu W, Wang X, Ding X, Li Y, Zhang X, Xie P, Yang J, et al. MicroRNA-141 represses HBV replication by targeting PPARA. PLoS One 2012; 7: e34165.

  22. Jin J, Tang S, Xia L, Du R, Xie H, Song J, Fan R, et al. MicroRNA- 501 promotes HBV replication by targeting HBXIP. Biochem Biophys Res Commun 2013; 430: 1228-33.

  23. Chen Y, Li L, Zhou Z, Wang N, Zhang CY, Zen K. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med Microbiol Immunol 2012; 201: 389-95.

  24. Gilli P, Stabellini N, Storari A, Gualandi G, Guerra G, Ghinelli F. Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Nephrol Dial Transplant 1996; 11: 526-8.

  25. Zhang X, Hou J, Lu M. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet 2013; 4: 202.

  26. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, et al. LNA-mediated microRNA silencing in nonhuman primates. Nature 2008; 452: 896-9.

  27. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.

  28. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-18.

  29. Huang C, Zheng JM, Cheng Q, Yu KK, Ling QX, Chen MQ, Li N. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. J Dig Dis 2014; 15: 614-21.

  30. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA- 29b in cultured human stellate cells. Biochem Biophys Res Commun 2010; 391: 316-21.

  31. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA- 29b. Biochem Biophys Res Commun 2011; 412: 74-9.

  32. Roderburg C, Luedde M, Vargas CD, Vucur M, Mollnow T, Zimmermann HW, Koch A, et al. miR-133a mediates TGFbeta- dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol 2013; 58: 736-42.

  33. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, et al. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One 2011; 6: e16081.

  34. Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N. Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair 2012; 5: 12.

  35. Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 2012; 61: 1600-9.

  36. Wang B, Li W, Guo K, Xiao Y, Wang Y, Fan J. miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem Biophys Res Commun 2012; 421: 4-8.

  37. Sharma AD, Narain N, Handel EM, Iken M, Singhal N, Cathomen T, Manns MP, et al. MicroRNA-221 regulates FAS-induced fulminant liver failure. Hepatology 2011; 53: 1651-61.

  38. An F, Gong B, Wang H, Yu D, Zhao G, Lin L, Tang W, et al. miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis 2012; 17: 702-16.

  39. Jiang H, He X, Li J, Xie Q, Lin J, Chang Y. Association of a single-nucleotide polymorphism within the miR-146a gene with susceptibility for acute-on-chronic hepatitis B liver failure. Immunogenetics 2013; 65: 257-63.

  40. Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hipposignaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010; 394: 623-7.

  41. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132: 330-42.

  42. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366-83.

  43. Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, Pan SH, Jiang HC, et al. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. J Gastroenterol Hepatol 2011; 26: 186-93.

  44. Zhu HT, Dong QZ, Sheng YY, Wei JW, Wang G, Zhou HJ, Ren N, et al. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. PLoS One 2012; 7: e52393.

  45. Jin XL, Sun QS, Liu F, Yang HW, Liu M, Liu HX, Xu W, et al. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. J Cell Biochem 2013; 114: 1625-33.

  46. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.

  47. Di Fazio P, Montalbano R, Neureiter D, Alinger B, Schmidt A, Merkel AL, Quint K, et al. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines. Exp Cell Res 2012; 318: 1832-43.

  48. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol 2010; 53: 57-66.

  49. Yang L, Ma Z, Wang D, Zhao W, Chen L, Wang G. Micro- RNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol Ther 2010; 9: 803-8.

  50. Fu X, Tan D, Hou Z, Hu Z, Liu G. miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3'-UTR Region of CyclinD1. Int J Mol Sci 2012; 13: 8514-39.

  51. Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z, Feitelson MA. Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 2012; 31: 563-72.

  52. Chen M, Zhang J, Li N, Qian Z, Zhu M, Li Q, Zheng J, et al. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One 2011; 6: e25564.

  53. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013; 25: 439-46.

  54. Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, et al. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 2013; 25: 1037-43.

  55. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA- 152 induces aberrant DNA methylation in hepatitis B virus- related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52: 60-70.

  56. Li C, Wang Y, Wang S, Wu B, Hao J, Fan H, Ju Y, et al. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol 2013; 87: 2193-205.

  57. Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, et al. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology 2013; 58: 1681-92.

  58. Jiang R, Deng L, Zhao L, Li X, Zhang F, Xia Y, Gao Y, et al. miR-22 promotes HBV-related hepatocellular carcinoma development in males. Clin Cancer Res 2011; 17: 5593-603.

  59. Wang Y, Jiang L, Ji X, Yang B, Zhang Y, Fu XD. Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes. J Biol Chem 2013; 288: 18484-93.

  60. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, Deng Y, et al. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012; 22: 291-303.

  61. Lan SH, Wu SY, Zuchini R, Lin XZ, Su IJ, Tsai TF, Lin YJ, et al. Autophagy suppresses tumorigenesis of hepatitis B virus- associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology 2014; 59: 505-17.

  62. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537-45.

  63. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29: 4781-8.

  64. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011; 6: e28486.




2020     |     www.medigraphic.com